CUL9 and neoplasm: CUL9 (formerly known as PARC) is a cytoplasmic, p53-binding protein, and a p53-dependent tumor suppressor in mice (Pei et al., 2011) as well as in murine and human leukemic cells (Seipel et al., 2016; Li and Xiong, 2017).